Intermediate for Vorapaxar. Vorapaxar (trade name: Zontivity) is a thrombin receptor (protease-activated receptor, PAR-1) antagonist. Vorapaxar is a new anti-platelet drug that and is used for persons with a history of myocardial infarction (heart attack) or persons with peripheral arterial disease. Vorapaxar has been approved by the U.S Food and Drug Administration on May 5, 2014.


Product Name:                  4-Hydroxy-N,N-diphenyl-(4R)-2-pentynamide

Synonyms:                         N/A

CAS Number:                     899809-61-1

Molecular Weight:            265.311

Molecular Formula:          C17H15NO2

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               C[C@H](C#CC(=O)N(c1ccccc1)c1ccccc1)O

  • $233.00
  • Ex Tax: $233.00

Available Options